Treace Medical Concepts' Upcoming Investor Conferences
Treace Medical Concepts, Inc. (NASDAQ: TMCI) is making waves in the medical technology sector, particularly known for its advancements in treating bunions and related midfoot deformities. The company is set to showcase its innovative solutions at two prominent investor conferences, highlighting its commitment to growth and investor engagement.
Conference Participation Details
UBS Global Healthcare Conference
On a significant date, Treace will be participating in the UBS Global Healthcare Conference. During this event, a live fireside chat is scheduled for 11:45 am ET, where industry experts will discuss the company's mission and technological advancements.
Stifel 2025 Healthcare Conference
Following the UBS event, Treace will take part in the Stifel 2025 Healthcare Conference. This involvement is an excellent opportunity for the company to engage with potential investors and showcase its impactful healthcare solutions.
Accessing Live Webcasts
For those interested in following these discussions, a live webcast will be available on the Treace investor relations website. This transparency reflects Treace's commitment to keeping its stakeholders informed about its strategic direction and market developments.
About Treace Medical Concepts, Inc.
Treace is dedicated to advancing the standard of care for bunion and midfoot deformity surgeries. With bunions affecting around 65 million people in the U.S. alone, Treace aims to address this medical issue head-on. They have developed the Lapiplasty® 3D Bunion Correction® System, which innovatively allows for the correction of bunions in multiple planes, ensuring stable results and quicker recoveries for patients.
Innovative Solutions and Product Offerings
In addition to the Lapiplasty system, Treace has created the Adductoplasty® Midfoot Correction System to assist surgeons in performing reliable corrections for various midfoot deformities. Their SpeedMTP™ Rapid Compression Implant further supports surgical procedures related to bunions, enhancing recovery time. Treace is made up of a team committed to ongoing innovation, tailoring its products to meet the evolving needs of foot and ankle surgeons.
Community Engagement and Awareness
Treace recognizes the importance of engaging with the medical community and its patients. By sharing information through their website and social media channels, they encourage discussions about their products and foster connections with healthcare professionals. Awareness initiatives are key to educating the public about bunion treatment options, ensuring patients remain informed.
Company Contact Information
For inquiries, Mark L. Hair, the Chief Financial Officer, is available for communication. Interested parties can reach out via email at mhair@treace.net or by phone at (904) 373-5940.
Join the Conversation
To stay updated on Treace's latest developments, follow them on various social media platforms such as LinkedIn, X, Facebook, and Instagram. Engaging with their content can provide valuable insights into the company's journey and innovations in medical technology.
Frequently Asked Questions
What does Treace Medical Concepts specialize in?
Treace specializes in medical technology aimed at treating bunions and midfoot deformities through innovative surgical methods.
When are the upcoming investor conferences?
The UBS Global Healthcare Conference is on November 10, 2025, while the Stifel 2025 Healthcare Conference follows on November 11, 2025.
How can I access the webcasts of the conferences?
The webcasts will be available on Treace's investor relations website, providing access to the discussions and insights shared during the conferences.
What innovative systems has Treace developed?
Treace has developed several systems including the Lapiplasty® 3D Bunion Correction® System and the Adductoplasty® Midfoot Correction System.
Who should I contact for more information?
For more information, reach out to Mark L. Hair via email at mhair@treace.net or call (904) 373-5940.